1. Home
  2. BOW vs LENZ Comparison

BOW vs LENZ Comparison

Compare BOW & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

HOLD

Current Price

$24.13

Market Cap

734.3M

Sector

Finance

ML Signal

HOLD

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$9.92

Market Cap

609.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOW
LENZ
Founded
2020
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
734.3M
609.5M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
BOW
LENZ
Price
$24.13
$9.92
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$32.29
$45.60
AVG Volume (30 Days)
159.7K
1.1M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
23.26
N/A
EPS
1.59
N/A
Revenue
$551,589,000.00
$19,088,000.00
Revenue This Year
$21.42
$51.35
Revenue Next Year
$19.41
$198.33
P/E Ratio
$15.38
N/A
Revenue Growth
29.58
N/A
52 Week Low
$21.21
$8.25
52 Week High
$41.98
$50.19

Technical Indicators

Market Signals
Indicator
BOW
LENZ
Relative Strength Index (RSI) 58.93 45.28
Support Level $23.72 $8.25
Resistance Level $26.17 $12.70
Average True Range (ATR) 0.80 0.68
MACD 0.32 0.20
Stochastic Oscillator 84.62 81.86

Price Performance

Historical Comparison
BOW
LENZ

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division, which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury, or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity, and hospitality segments, and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Share on Social Networks: